BioNtech-Pfizer claims their Vaccine is effective against new Covid strain

BioNTech has claimed that it can produce a vaccine that eliminates corona virus mutations in six weeks. Therefore, there is absolutely no need to panic.

Yogita S.
Published on: 23 Dec 2020 4:48 AM GMT
BioNtech-Pfizer claims their Vaccine is effective against new Covid strain
X

New Delhi: The new strain (altered form) of corona virus has left the whole world awed. Many countries have begun an exercise to seal their borders. India too has devised a strategy to deal with this new threat of corona virus. Meanwhile, BioNTech has given good news.

Vaccine for new form of Corona Virus:

BioNTech has claimed that it can produce a vaccine that eliminates corona virus mutations in six weeks. Therefore, there is absolutely no need to panic. With Biotech, Pfizer claimed that their vaccine was able to combat the new strains of the corona virus. BioNTech CEO Ugur Sahin said the scientific community was confident that Pfizer and Biotech's vaccine would still be effective against new and faster infections of covid-19.

ALSO READ: India’s Corona tally climbs to 1 crore with 26,624 new Covid-19 cases

BioNtech believes their vaccine is helpful:

Actually, many questions are arising in the minds of people about the changed form of corona virus. One of these questions is whether Corona's current vaccine is capable of fighting in the form of Covid-19 or not. However, experts believe the current vaccine is capable of fighting this changed form of corona.

CSIR's DG doctor Shekhar Mande says, 'It is generally believed that the vaccine is meant to fight any mutation from the virus, as these are very minor mutations. Antibodies originating in the body are against the whole virus. In theory the vaccine would be effective against the mutated virus. '

ALSO READ: Two doses of Oxford Corona Vaccine provoked good immune response

Corona virus vaccine companies have not yet been able to give a clear answer as to whether their vaccine is capable of fighting the virus-type form? UGar Sahin, co-founder of BioNTech Company, says that scientifically there is a high chance that the immunity of this vaccine can deal with this changed form of the virus as well. '

Stay tuned with the newstrack to get fastest updates. Click @englishnewstrack to follow us on Facebook and @newstrackmedia to follow on Twitter.

Yogita S.

Yogita S.

Media Graduate, News Editor and PR Enthusiast.

Next Story